MARC

LEADER 00000cam a2200000Mu 4500
001 EBOOKCENTRAL_ocn923260981
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|||||||||
008 151010s1900 dcu o 000 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d MERUC  |d ZCU  |d ICG  |d OCLCO  |d OCLCF  |d OCLCQ  |d OCLCO  |d OCLCQ  |d DKC  |d AU@  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
020 |a 9780309587648 
020 |a 0309587646 
029 1 |a DEBBG  |b BV044106807 
035 |a (OCoLC)923260981 
043 |a n-us--- 
050 4 |a RC78.7.R4I 
082 0 4 |a 541.388 
049 |a UAMI 
100 1 |a Staff, Institute of Medicine. 
245 1 0 |a Isotopes for Medicine and the Life Sciences. 
260 |a Washington :  |b National Academies Press,  |c 1900. 
300 |a 1 online resource (144 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a ""Isotopes for Medicine and the Life Sciences""; ""Copyright""; ""Preface""; ""Contents""; ""Executive Summary""; ""ENRICHED STABLE ISOTOPES""; ""REACTOR-PRODUCED RADIONUCLIDES""; ""ACCELERATOR-PRODUCED RADIONUCLIDES""; ""PUBLIC-PRIVATE PARTNERSHIP MODELS FOR NBTF""; ""A NATIONAL ISOTOPE POLICY""; ""1 Introduction""; ""CHARGE TO THE COMMITTEE""; ""PLAN OF THE REPORT""; ""REFERENCES""; ""2 Enriched Stable Isotopes""; ""HISTORICAL PERSPECTIVE""; ""CURRENT APPLICATIONS IN MEDICINE AND PHYSICAL AND LIFE SCIENCES""; ""ISOTOPE SEPARATION IN THE UNITED STATES""; ""FUTURE SUPPLIES"" 
505 8 |a ""NEW AND ALTERNATIVE SEPARATION TECHNOLOGIES""""CONCLUSIONS""; ""RECOMMENDATIONS""; ""REFERENCES""; ""3 Reactor-Produced Radionuclides""; ""HISTORICAL PERSPECTIVE""; ""CURRENT APPLICATIONS IN MEDICINE AND PHYSICAL AND LIFE SCIENCES""; ""SUPPLIES AND SUPPLIERS""; ""Molybdenum-99""; ""Current Sources""; ""Future Sources""; ""Research and Development on Alternative Sources""; ""Other Commercial Radionuclides""; ""Research Radionuclides""; ""Market Analyses""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""REFERENCES""; ""4 Accelerator-Produced Radionuclides and a National BiomedicalTracer Facility"" 
505 8 |a ""HISTORICAL PERSPECTIVE""""CURRENT APPLICATIONS IN MEDICINE AND PHYSICAL AND LIFE SCIENCES""; ""SUPPLIES AND SUPPLIERS""; ""Commercially Available Radioisotopes""; ""Short-Lived Radioisotopes for PET""; ""Radionuclides Currently Produced at DOE Facilities""; ""BLIP""; ""LAMPF""; ""TRIUMF""; ""Future Production""; ""Proposed NBTF""; ""Upgraded BLIP""; ""In-House Research and Education at the NBTF""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""REFERENCES""; ""5 Public-Private Partnership Models for NBTF""; ""THE DOE ISOTOPE PRODUCTION AND DISTRIBUTION PROGRAM""; ""CANADA'S TRIUMF"" 
505 8 |a ""NORDION AND ISOTOPES""""UNIVERSITIES AND NATIONAL LABORATORIES IN RESEARCH""; ""DOE LABORATORY AND UNIVERSITY PARTNERSHIPS WITH COMMERCIAL VENTURES""; ""Radiation Therapy at Brookhaven""; ""Continuous Electron Beam Accelerator Facility (CEBAF)""; ""Technology Transfer and Cooperative Agreements""; ""POSSIBLE MODEL FOR NBTF""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""REFERENCES""; ""6 A National Isotope Policy: Proposal for a New Way to Manage theNation's Isotope Resources""; ""CONCLUSIONS""; ""RECOMMENDATIONS""; ""APPENDIXES""; ""APPENDIX A Waste Management"" 
505 8 |a ""NATURE AND SOURCES OF LOW-LEVEL RADIOACTIVE WASTE (LLRW)""""RISK FROM LLRW""; ""DISPOSAL SITES""; ""IMPLICATIONS FOR ISOTOPE PRODUCTION AND USE""; ""REFERENCES""; ""APPENDIX B Legal Considerations""; ""THE ATOMIC ENERGY ACT OF 1954""; ""PUBLIC LAW 101-101""; ""THE TECHNOLOGY TRANSFER ACT OF 1986""; ""ANTI-TRUST CONSIDERATIONS""; ""REFERENCES""; ""APPENDIX C Acronyms and Abbreviations""; ""APPENDIX D Table of Elements""; ""APPENDIX E Glossary"" 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Radioisotopes in medical diagnosis  |z United States. 
650 0 |a Radioisotopes  |x Therapeutic use  |z United States. 
650 0 |a Life sciences  |x Research  |z United States. 
650 0 |a Radioisotopes in research  |z United States. 
650 6 |a Isotopes radioactifs dans le diagnostic  |z États-Unis. 
650 6 |a Curiethérapie  |z États-Unis. 
650 6 |a Sciences de la vie  |x Recherche  |z États-Unis. 
650 6 |a Isotopes radioactifs dans la recherche  |z États-Unis. 
650 7 |a Life sciences  |x Research  |2 fast 
650 7 |a Radioisotopes in medical diagnosis  |2 fast 
650 7 |a Radioisotopes in research  |2 fast 
650 7 |a Radioisotopes  |x Therapeutic use  |2 fast 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
700 1 |a Adelstein, S. James. 
700 1 |a Manning, Frederick J. 
758 |i has work:  |a Isotopes for medicine and the life sciences (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCG6FvRWxPjMbcP4mmMyvtq  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Staff, Institute of Medicine.  |t Isotopes for Medicine and the Life Sciences.  |d Washington : National Academies Press, ©1900  |z 9780309051903 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3376097  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3376097 
994 |a 92  |b IZTAP